MedTrace Logo

Implementation of Enhanced Recovery in Women Undergoing Cesarean Delivery

NCT05841888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-05-03

No results posted yet for this study

Summary

Aim: The aim of our study was to evaluate the outcomes in women who implemented the ERAS (Enhanced Recovery after Surgery) protocol at delivery by cesarean delivery(CD).

Methods: The women who underwent CD with ERAS or standard perioperative care (SC) were randomized. In terms of the time to first flatus (TFF), visual pain score (VAS), successful breastfeeding, time of initiation of breastfeeding, time to returning to daily activities, hemoglobin values, postoperative nausea and vomiting, readmission to the hospital, postoperative wound infection, postpartum blues (PB) and the need for blood transfusion were compared between two groups.

Conditions

  • The Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at Delivery by Cesarean Delivery

Sponsors & Collaborators

  • Duygu Yıldız Birden

    collaborator UNKNOWN

  • Alper Başbuğ

    collaborator UNKNOWN

  • Ali Yavuzcan

    collaborator UNKNOWN

  • Ali Yavuzcan

    lead OTHER

Principal Investigators

  • Ali S Yavuzcan, PhD · Duzce University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2021-02-17
Completion
2021-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05841888 on ClinicalTrials.gov